Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Cash from Investing Activities (2016 - 2022)

Historic Cash from Investing Activities for Palisade Bio (PALI) over the last 11 years, with Q4 2022 value amounting to -$10000.0.

  • Palisade Bio's Cash from Investing Activities changed N/A to -$10000.0 in Q4 2022 from the same period last year, while for Sep 2024 it was -$10000.0, marking a year-over-year increase of 909.09%. This contributed to the annual value of -$4000.0 for FY2023, which is 6000.0% up from last year.
  • Palisade Bio's Cash from Investing Activities amounted to -$10000.0 in Q4 2022.
  • Over the past 5 years, Palisade Bio's Cash from Investing Activities peaked at $5.0 million during Q1 2018, and registered a low of -$10000.0 during Q4 2022.
  • For the 3-year period, Palisade Bio's Cash from Investing Activities averaged around $997657.2, with its median value being -$1000.0 (2020).
  • Over the last 5 years, Palisade Bio's Cash from Investing Activities had its largest YoY gain of 32009.8% in 2018, and its largest YoY loss of 32009.8% in 2018.
  • Quarter analysis of 3 years shows Palisade Bio's Cash from Investing Activities stood at -$1714.0 in 2018, then surged by 41.66% to -$1000.0 in 2020, then tumbled by 900.0% to -$10000.0 in 2022.
  • Its last three reported values are -$10000.0 in Q4 2022, -$1000.0 for Q4 2020, and $1000.0 during Q3 2020.